These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 30636212)

  • 1. Current challenges in the development of new treatments for lupus.
    Dall'Era M; Bruce IN; Gordon C; Manzi S; McCaffrey J; Lipsky PE
    Ann Rheum Dis; 2019 Jun; 78(6):729-735. PubMed ID: 30636212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.
    Medina-Rosas J; Al-Rayes H; Moustafa AT; Touma Z
    Expert Opin Biol Ther; 2016 Oct; 16(10):1225-38. PubMed ID: 27429254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison and evaluation of lupus nephritis response criteria in lupus activity indices and clinical trials.
    Corapi KM; Dooley MA; Pendergraft WF
    Arthritis Res Ther; 2015 Apr; 17(1):110. PubMed ID: 25927414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic therapies in systemic lupus erythematosus.
    Bernal CB; Zamora LD; Navarra SV
    Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa.
    Lewandowski LB; Schanberg LE; Thielman N; Phuti A; Kalla AA; Okpechi I; Nourse P; Gajjar P; Faller G; Ambaram P; Reuter H; Spittal G; Scott C
    Lupus; 2017 Feb; 26(2):186-194. PubMed ID: 27488473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus clinical trials-an interim analysis.
    Dall'Era M; Wofsy D
    Nat Rev Rheumatol; 2009 Jun; 5(6):348-51. PubMed ID: 19491915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical review of clinical trials in systemic lupus erythematosus.
    Mahieu MA; Strand V; Simon LS; Lipsky PE; Ramsey-Goldman R
    Lupus; 2016 Sep; 25(10):1122-40. PubMed ID: 27497257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous cyclophosphamide pulse therapy in Japanese children with systemic lupus erythematosus.
    Igarashi T; Igarashi T; Shimizu A; Itoh Y
    J Nippon Med Sch; 2013; 80(5):396-400. PubMed ID: 24189359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lima GL; Paupitz J; Aikawa NE; Takayama L; Bonfa E; Pereira RM
    Arthritis Care Res (Hoboken); 2016 Jan; 68(1):91-8. PubMed ID: 25988278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE): study protocol for a randomized controlled trial.
    Olsen NJ; James JA; Arriens C; Ishimori ML; Wallace DJ; Kamen DL; Chong BF; Liao D; Chinchilli VM; Karp DR
    Trials; 2018 Dec; 19(1):694. PubMed ID: 30572906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?
    Runkel L; Stacey J
    Expert Opin Biol Ther; 2014 Apr; 14(4):491-501. PubMed ID: 24490627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologics as treatment for systemic lupus: great efforts, sobering results, new challenges.
    Schröder JO; Zeuner RA
    Curr Drug Discov Technol; 2009 Dec; 6(4):252-5. PubMed ID: 20025592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open label randomized controlled trial assessing the efficacy of mycophenolate sodium against other conventional immunosuppressive agents in active systemic lupus erythematosus patients without renal involvement.
    Yahya F; Jasmin R; Ng CT; Cheah TE; Sockalingam S
    Int J Rheum Dis; 2013 Dec; 16(6):724-30. PubMed ID: 24119227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One year in review 2018: systemic lupus erythematosus.
    Di Battista M; Marcucci E; Elefante E; Tripoli A; Governato G; Zucchi D; Tani C; Alunno A
    Clin Exp Rheumatol; 2018; 36(5):763-777. PubMed ID: 30272543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA; Houssiau F; Aranow C; D'Cruz DP; Askanase A; Roth DA; Zhong ZJ; Cooper S; Freimuth WW; Ginzler EM;
    Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.
    Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
    Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
    Zhang H; Chambers W; Sciascia S; Cuadrado MJ
    Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials and tribulations in systemic lupus erythematosus.
    Wofsky D
    Bull NYU Hosp Jt Dis; 2010; 68(3):175-8. PubMed ID: 20969548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.